Proteomic Analysis of Plasma-Derived Extracellular Vesicles in Smokers and Patients with Chronic Obstructive Pulmonary Disease
Authors:
Open Access
- 19 June 2019
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 4 (6) , 10649-10661
Abstract
Circulating biomarkers using targeted approaches from human plasma-derived extracellular vesicles (EVs) in the pathobiology of chronic obstructive pulmonary disease (COPD) are an emerging tool. There are several challenges in the field of EV proteomics. We used different EV isolation methods (ExoQuick and Exo-Spin) for purification of human plasma-derived EVs from nonsmokers, smokers, and patients with COPD. Furthermore, characterization of plasma-derived EVs was performed based on their size, particle concentrations, surface markers, and acetylcholinesterase activity. Additionally, we performed label-free MS analysis of plasma-derived EVs isolated by two different methods for comparison. We performed a thorough analysis of EV markers from the identified peptides and peptide-spectrum matches using the four main databases on EV biomolecules. We found several common EV markers enriched in our data set compared with top 100 plasma-derived EV markers from databases. Using a pairwise comparison, we identified several novel proteins such as CD5L, FN1, CLU, GSN, HABP2, APOD, and EFEMP1 differentially enriched in smokers and patients with COPD compared to nonsmokers. This pilot study demonstrates the importance of EV isolation and characterization from plasma. Thus, it facilitates the identification of novel circulating EV biomarkers as a tool for prognostics, diagnostics, and therapeutics of chronic inflammatory lung diseases.Keywords
Funding Information
- National Institute of Environmental Health Sciences (ES028006)
- National Center for Advancing Translational Sciences (UL1 TR002001)
- National Heart, Lung, and Blood Institute (HL135613, HL137738, 2R01HL085613)
This publication has 69 references indexed in Scilit:
- HMGB1 and Microparticles as Mediators of the Immune Response to Cell DeathAntioxidants & Redox Signaling, 2011
- Role of hyaluronan and hyaluronan-binding proteins in lung pathobiologyAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2011
- Circulating Endothelial Microparticles as a Measure of Early Lung Destruction in Cigarette SmokersAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Membrane vesicles, current state-of-the-art: emerging role of extracellular vesiclesCellular and Molecular Life Sciences, 2011
- Platelets Amplify Inflammation in Arthritis via Collagen-Dependent Microparticle ProductionScience, 2010
- Procoagulant alveolar microparticles in the lungs of patients with acute respiratory distress syndromeAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2009
- Membrane vesicles as conveyors of immune responsesNature Reviews Immunology, 2009
- Characterization of exosome‐like vesicles released from human tracheobronchial ciliated epithelium: a possible role in innate defenseThe FASEB Journal, 2009
- Tracheobronchial air-liquid interface cell culture: a model for innate mucosal defense of the upper airways?American Journal of Physiology-Lung Cellular and Molecular Physiology, 2009
- Raised protein levels and altered cellular expression of factor VII activating protease (FSAP) in the lungs of patients with acute respiratory distress syndrome (ARDS)Thorax, 2007